The fact that The Unscrambler® 9.7 further complies with the FDA's 21 CFR Part 11 guidelines and the new 3rd order variable interaction, is a telling testament on CAMO Software's dedicated attention to the Pharmaceutical market. The improved MLR and MCR will also focus on projection methods i.e.: PLS regression. The new version also contains a file merge featers along with MSC and EMSC model files. According to the statement, the new version of the software addresses the needs of a wider range of data analysts, thanks to the implementation Data Pretreatments simplification, Sample Grouping, MyInstruments driver, 3rd Order Variable Interactions and more. In a statement released today, CAMO Software AS announced the launch of The Unscrambler® 9.7.